JONATHAN MATTHEW SHARRETT
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology POST FALLS, ID NPI 1275910960
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology ID Stemline Therapeutics Inc. All categories
General Payments — all program years on this page
$578.31
- Category: General Payments
- Program years: PY2019–2024
- Record count: 22
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $178.83 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $178.83 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Stemline Therapeutics Inc. | $51.79 | 2 |
| PFIZER INC. | $46.72 | 2 |
| Incyte Corporation | $23.44 | 1 |
| Merck Sharp & Dohme Corporation | $21.86 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.62 | 1 |
| ADC Therapeutics America, Inc. | $17.40 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087315725 | Novartis Pharmaceuticals Corporation | $17.62 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1121190389 | ADC Therapeutics America, Inc. | $17.40 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132051930 | PFIZER INC. | $22.81 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132064913 | PFIZER INC. | $23.91 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141270372 | Incyte Corporation | $23.44 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141776481 | Merck Sharp & Dohme LLC | $21.86 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142960931 | Stemline Therapeutics Inc. | $27.10 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142960933 | Stemline Therapeutics Inc. | $24.69 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.